| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |